4.3049
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RCEL Giù?
Forum
Previsione
Frazionamento azionario
Avita Medical Inc Borsa (RCEL) Ultime notizie
Avita Medical Stock Price Forecast. Should You Buy RCEL? - StockInvest.us
Avita Medical Q1 earnings call highlights - MSN
Morgans says these ASX shares could rise 12% to 20% - MSN
Insider Buying: David O'Toole Acquires Shares of AVITA Medical I - GuruFocus
AVITA Medical (RCEL) CFO adds 2,000 shares in open-market buy - Stock Titan
AVITA Medical (RCEL) CFO adds 2,000 shares in open-market purchase - Stock Titan
AVITA Medical to Host Investor Webinar Briefing - Investing News Network
AVITA Medical to Host Investor Webinar Briefing | Associated Press | syndication news - Enidnews.com
Two AVITA Medical investor Q&As with CEO Cary Vance on May 20–21 - Stock Titan
AVITA Medical, Inc. (NASDAQ:RCEL) Q1 2026 Earnings Call Transcript - Insider Monkey
AVITA Medical Q1 2026 earnings preview - MSN
RCEL Upgraded by Lake Street -- Price Target Raised to $6.00 - GuruFocus
Avita Medical Raised to Buy From Hold by Lake Street - Moomoo
Avita Medical, Inc. Stock 12‑Month Price Target Raised to $6.99, Implies 60% Upside - TradingView
Avita (RCEL) Q1 2026 Earnings Call Transcript - The Globe and Mail
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $5.5 - Moomoo
AVITA Medical, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Avita reaffirms $80M-$85M 2026 revenue guidance as RECELL reimbursement normalizes and Cohealyx data targets faster graft readiness - MSN
Lake Street upgrades AVITA Medical (RCEL) - MSN
RCEL Reports Q1 Revenue Below Expectations - GuruFocus
RCEL Revenue Forecast for FY26 Indicates Strong Growth Potential - GuruFocus
Is AVITA Medical (RCEL) a Value Trap Despite Q1 2026 Revenue Bea - GuruFocus
AVITA Medical Inc (AVHHL) Q1 2026 Earnings Call Highlights: Reve - GuruFocus
Avita Medical Posts Narrower Q1 Loss, Higher Revenue; Reaffirms Full-Year 2026 Outlook - Moomoo
AVITA Medical's (ASX:AVH) First Quarter 2026 Results and Strategic Reset Explained - Kalkine
Avita Medical Q1 Earnings Call Highlights - MarketBeat
AVITA Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
RCEL: Revenue rose 4% year-over-year to $19.3M, with improved margins and reaffirmed guidance - TradingView
Avita Medical earnings missed by $0.06, revenue topped estimates - Investing.com Canada
AVITA Medical Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
AVITA Medical Reports First Quarter 2026 Financial Results - Investing News Network
Avita Medical stock (US0301011039): Q1 2026 results and revenue details - AD HOC NEWS
RCEL: Q1 2026 delivered revenue growth, improved margins, and strong clinical momentum for new products - TradingView
Q1 2026 AVITA Medical Inc Earnings Call Transcript - GuruFocus
AVITA Medical (RCEL) posts Q1 2026 loss, adds new credit line and BARDA deal - Stock Titan
AVITA Medical (RCEL) Q1 2026 revenue rises 4% as losses narrow and 2026 outlook held - Stock Titan
AVITA Medical, Inc. Reaffirms Earnings Guidance for the Full Year 2026 - marketscreener.com
AVITA Medical Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Avita Medical stock (US0301011039): Shares surged 7.75% in July 2025 - AD HOC NEWS
TradingKey - TradingKey
Avita Medical Inc. (NASDAQ:RCEL) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
AVITA Medical Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
RCEL Stock Price, Quote & Chart | AVITA MEDICAL INC (NASDAQ:RCEL) - ChartMill
Avita Medical (RCEL) Expected to Announce Earnings on Thursday - MarketBeat
AVITA Medical appoints Cary Vance as permanent CEO - MSN
AVITA Medical Appoints Cary Vance as Permanent CEO and Jan Stern Reed as Board Chair to Drive Growth in Acute Wound Care Solutions - Minichart
Avita Medical Names Cary Vance Permanent CEO, Reshapes Board - The Globe and Mail
Avita Medical (NASDAQ:RCEL) Stock Rating Lowered by Wall Street Zen - MarketBeat
AVITA Medical wins BARDA contract worth up to $25.5M - MSN
Cary Vance becomes AVITA Medical (NASDAQ: RCEL) CEO as Board elevates Jan Stern Reed to Chair - Stock Titan
Avita Medical Appoints CEO, Chair - Moomoo
AVITA Medical Names Cary Vance as Chief Executive Officer - Investing News Network
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):